Curis
CRIS
#10263
Rank
โ‚ฌ9.76 M
Marketcap
0,71ย โ‚ฌ
Share price
-8.58%
Change (1 day)
-72.61%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -โ‚ฌ29.24 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ11.65 Million. In 2024 the company made an earning of -โ‚ฌ37.32 Million, an increase over its 2023 earnings that were of -โ‚ฌ39.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ29.24 Million-21.66%
2024 -โ‚ฌ37.32 Million-5.77%
2023 -โ‚ฌ39.61 Million-13.1%
2022 -โ‚ฌ45.58 Million27.52%
2021 -โ‚ฌ35.74 Million65.09%
2020 -โ‚ฌ21.65 Million-9.1%
2019 -โ‚ฌ23.82 Million-4.73%
2018 -โ‚ฌ25 Million-41.95%
2017 -โ‚ฌ43.06 Million-14.37%
2016 -โ‚ฌ50.28 Million3.55%
2015 -โ‚ฌ48.56 Million271.52%
2014 -โ‚ฌ13.07 Million76.64%
2013 -โ‚ฌ7.4 Million
2011 -โ‚ฌ6.29 Million27.76%
2010 -โ‚ฌ4.92 Million-43.87%
2009 -โ‚ฌ8.77 Million-23.44%
2008 -โ‚ฌ11.45 Million56.66%
2007 -โ‚ฌ7.31 Million-16.71%
2006 -โ‚ฌ8.78 Million-36.92%
2005 -โ‚ฌ13.91 Million156.25%
2004 -โ‚ฌ5.43 Million-37.24%
2003 -โ‚ฌ8.65 Million-93.34%
2002 -โ‚ฌ0.13 Billion86.79%
2001 -โ‚ฌ69.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ10.33 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.00 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.99 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.76 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.23 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ21.61 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA